These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1109 related articles for article (PubMed ID: 27038129)

  • 21. Inhibition of non-muscle myosin II leads to G0/G1 arrest of Wharton's jelly-derived mesenchymal stromal cells.
    Sharma T; Kumari P; Pincha N; Mutukula N; Saha S; Jana SS; Ta M
    Cytotherapy; 2014 May; 16(5):640-52. PubMed ID: 24210786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
    Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Platelet Lysate Supports Efficient Expansion and Stability of Wharton's Jelly Mesenchymal Stromal Cells via Active Uptake and Release of Soluble Regenerative Factors.
    Cañas-Arboleda M; Beltrán K; Medina C; Camacho B; Salguero G
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32877987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of mesenchymal stem cells derived from Wharton's jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage.
    Liu S; Hou KD; Yuan M; Peng J; Zhang L; Sui X; Zhao B; Xu W; Wang A; Lu S; Guo Q
    J Biosci Bioeng; 2014 Feb; 117(2):229-235. PubMed ID: 23899897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
    He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
    Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank.
    Chatzistamatiou TK; Papassavas AC; Michalopoulos E; Gamaloutsos C; Mallis P; Gontika I; Panagouli E; Koussoulakos SL; Stavropoulos-Giokas C
    Transfusion; 2014 Dec; 54(12):3108-20. PubMed ID: 24894363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exendin-4 enhances the differentiation of Wharton's jelly mesenchymal stem cells into insulin-producing cells through activation of various β-cell markers.
    Kassem DH; Kamal MM; El-Kholy Ael-L; El-Mesallamy HO
    Stem Cell Res Ther; 2016 Aug; 7(1):108. PubMed ID: 27515427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Wharton's jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: new perspectives for cellular therapy.
    La Rocca G; Lo Iacono M; Corsello T; Corrao S; Farina F; Anzalone R
    Curr Stem Cell Res Ther; 2013 Jan; 8(1):100-13. PubMed ID: 23317435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.
    Datta I; Mishra S; Mohanty L; Pulikkot S; Joshi PG
    Cytotherapy; 2011 Sep; 13(8):918-32. PubMed ID: 21696238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and in vitro expansion.
    Margossian T; Reppel L; Makdissy N; Stoltz JF; Bensoussan D; Huselstein C
    Biomed Mater Eng; 2012; 22(4):243-54. PubMed ID: 22785368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human-derived extracellular matrix from Wharton's jelly: An untapped substrate to build up a standardized and homogeneous coating for vascular engineering.
    Dan P; Velot É; Francius G; Menu P; Decot V
    Acta Biomater; 2017 Jan; 48():227-237. PubMed ID: 27769940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ROCK inhibitor Y-27632 increases thaw-survival rates and preserves stemness and differentiation potential of human Wharton's jelly stem cells after cryopreservation.
    Gauthaman K; Fong CY; Subramanian A; Biswas A; Bongso A
    Stem Cell Rev Rep; 2010 Dec; 6(4):665-76. PubMed ID: 20711690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin.
    Hendijani F; Javanmard SH; Sadeghi-aliabadi H
    Tissue Cell; 2015 Jun; 47(3):229-34. PubMed ID: 25779671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lovastatin protects chondrocytes derived from Wharton's jelly of human cord against hydrogen-peroxide-induced in vitro injury.
    Wajid N; Mehmood A; Bhatti FU; Khan SN; Riazuddin S
    Cell Tissue Res; 2013 Mar; 351(3):433-43. PubMed ID: 23271636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
    Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
    Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
    Obradovic H; Krstic J; Trivanovic D; Mojsilovic S; Okic I; Kukolj T; Ilic V; Jaukovic A; Terzic M; Bugarski D
    Placenta; 2019 Jul; 82():25-34. PubMed ID: 31174623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteogenic differentiation of human mesenchymal stem cells from adipose tissue and Wharton's jelly of the umbilical cord.
    Zajdel A; Kałucka M; Kokoszka-Mikołaj E; Wilczok A
    Acta Biochim Pol; 2017; 64(2):365-369. PubMed ID: 28600911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro.
    Corsello T; Amico G; Corrao S; Anzalone R; Timoneri F; Lo Iacono M; Russo E; Spatola GF; Uzzo ML; Giuffrè M; Caprnda M; Kubatka P; Kruzliak P; Conaldi PG; La Rocca G
    Stem Cell Rev Rep; 2019 Dec; 15(6):900-918. PubMed ID: 31741193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preeclampsia enhances neuroglial marker expression in umbilical cord Wharton's jelly-derived mesenchymal stem cells.
    Joerger-Messerli M; Brühlmann E; Bessire A; Wagner A; Mueller M; Surbek DV; Schoeberlein A
    J Matern Fetal Neonatal Med; 2015 Mar; 28(4):464-9. PubMed ID: 24803009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential mechanisms underlying ectodermal differentiation of Wharton's jelly mesenchymal stem cells.
    Jadalannagari S; Berry AM; Hopkins RA; Bhavsar D; Aljitawi OS
    Biochem Biophys Res Commun; 2016 Sep; 478(2):831-7. PubMed ID: 27501759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.